Home・Lista de Ações・Tandem Diabetes Care Inc

Tandem Diabetes Care Inc

Fechado

SetorSaúde

22.55 20.59

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

18.41

Máximo

19.48

Indicadores-chave
By Trading Economics
Rendimento	-20M -20M
Vendas	-43M 247M
EPS	-0.3
Margem de lucro	-8.249
Funcionários	2,500
EBITDA	-25M -14M

Recomendações
By TipRanks
Recomendações	Comprar
Previsão para 12 meses	+43.8% upside

Dividendos
By Acuity
Próximos Ganhos	6 de ago. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	17M 1.4B
Abertura anterior	1.96
Fecho anterior	22.55

Sentimento de Notícias

By Acuity

50%

156 / 340 Ranking em Healthcare

Tandem Diabetes Care Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

5 de ago. de 2026, 19:56 UTC

News

Tandem Diabetes Care Inc's shares are declining amid negative sentiment in the insulin sector following Insulet Corp's lowered revenue growth forecast.

4 de ago. de 2026, 19:46 UTC

Tandem Diabetes Care Inc shares are lower today, influenced by declines in the Health Care Equipment sub-sector. Earlier, the stock reached a session high before pulling back.

31 de jul. de 2026, 19:51 UTC

Tandem Diabetes Care Inc is advancing today, benefiting from positive market sentiment driven by technology stocks, despite pulling back from earlier session highs.

30 de jul. de 2026, 17:11 UTC

Tandem Diabetes Care shares are lower today as the Health Care Equipment sub-sector declines. The asset remains above its 20-day moving average.

29 de jul. de 2026, 18:15 UTC

Tandem Diabetes Care Inc. shares are higher, driven by significant gains in Health Care Equipment stocks, despite a recent trend of daily price increases.

27 de jul. de 2026, 19:21 UTC

Tandem Diabetes Care Inc. shares are lower, reflecting broader market trends amid declining oil prices and easing geopolitical tensions ahead of the Federal Reserve meeting.

24 de jul. de 2026, 14:02 UTC

Tandem Diabetes Care Inc shares are lower today, with no specific news identified. Broader market concerns follow a significant sell-off on Thursday.

21 de jul. de 2026, 19:06 UTC

Tandem Diabetes Care is lower today, driven by declines in the Health Care Equipment sub-sector. The asset has fallen steadily after an early high.

20 de jul. de 2026, 17:26 UTC

Tandem Diabetes Care Inc shares are higher today, recovering from an early dip. The stock has gained significantly since last month’s close.

Comparação entre Pares

Variação de preço

Tandem Diabetes Care Inc Previsão

Preço-alvo

By TipRanks

43.8% parte superior

Previsão para 12 meses

Média 28.17 USD 43.8%

Máximo 55 USD

Mínimo 15.5 USD

Com base em 16 analistas de Wall Street que oferecem metas de preço de 12 meses para Tandem Diabetes Care Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

16 ratings

Comprar

Manter

Vender

Com base em 16 analistas que deram avaliações de ações para Tandem Diabetes Care Inc - Dist nos últimos 3 meses.

Sentimento

By Acuity

156 / 340 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.